{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:44:41Z","timestamp":1763415881228,"version":"3.45.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medicine and Health Technology Project of Shandong Province","award":["202303090790"],"award-info":[{"award-number":["202303090790"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07400-3","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:52:58Z","timestamp":1763412778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A study on the effect of COVID-19 infection on the serum concentration of antipsychotic drugs"],"prefix":"10.1186","volume":"25","author":[{"given":"Taixiu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruirui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"7400_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112752","volume":"172","author":"M Y\u00fcce","year":"2021","unstructured":"Y\u00fcce M, Filiztekin E, \u00d6zkaya KG. COVID-19 diagnosis - a review of current methods. Biosens Bioelectron. 2021;172:112752.","journal-title":"Biosens Bioelectron"},{"issue":"3","key":"7400_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"7400_CR3","first-page":"20","volume":"29","author":"R Ochani","year":"2021","unstructured":"Ochani R, et al. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med. 2021;29(1):20\u201336.","journal-title":"Infez Med"},{"issue":"12","key":"7400_CR4","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/14787210.2020.1797487","volume":"18","author":"K Habas","year":"2020","unstructured":"Habas K, et al. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti-Infect Ther. 2020;18(12):1201\u201311.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1","key":"7400_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/FTD.0b013e31827ada88","volume":"35","author":"J de Leon","year":"2013","unstructured":"de Leon J, Spina E, Diaz FJ. Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies. Ther Drug Monit. 2013;35(1):30\u201347.","journal-title":"Ther Drug Monit"},{"issue":"1\u201302","key":"7400_CR6","first-page":"9","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1\u201302):9\u201362.","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"7400_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","volume":"209","author":"D Siskind","year":"2016","unstructured":"Siskind D, et al. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2016;209(5):385\u201392.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"7400_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/acps.12700","volume":"135","author":"R Land","year":"2017","unstructured":"Land R, et al. The impact of clozapine on hospital use: a systematic review and meta-analysis. Acta Psychiatr Scand. 2017;135(4):296\u2013309.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"7400_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/schbul\/sby052","volume":"45","author":"JM Vermeulen","year":"2019","unstructured":"Vermeulen JM, et al. Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1\u201312.5 years. Schizophr Bull. 2019;45(2):315\u201329.","journal-title":"Schizophr Bull"},{"key":"7400_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.taap.2016.12.003","volume":"316","author":"F Regen","year":"2017","unstructured":"Regen F, et al. Clozapine-induced agranulocytosis: evidence for an immune-mediated mechanism from a patient-specific in-vitro approach. Toxicol Appl Pharmacol. 2017;316:10\u20136.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"7400_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.12898","volume":"138","author":"N Myles","year":"2018","unstructured":"Myles N, et al. Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatr Scand. 2018;138(2):101\u20139.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"7400_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40263-016-0311-1","volume":"30","author":"J Nielsen","year":"2016","unstructured":"Nielsen J, et al. Worldwide differences in regulations of clozapine use. CNS Drugs. 2016;30(2):149\u201361.","journal-title":"CNS Drugs"},{"issue":"2","key":"7400_CR13","doi-asserted-by":"publisher","first-page":"E232","DOI":"10.1503\/jpn.200208","volume":"46","author":"S Gee","year":"2021","unstructured":"Gee S, Taylor D. COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine. J Psychiatry Neurosci. 2021;46(2):E232\u20137.","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"7400_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000507638","volume":"89","author":"J de Leon","year":"2020","unstructured":"de Leon J, et al. A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology. Psychother Psychosom. 2020;89(4):200\u201314.","journal-title":"Psychother Psychosom"},{"key":"7400_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","volume":"192","author":"SR Clark","year":"2018","unstructured":"Clark SR, et al. Elevated clozapine levels associated with infection: a systematic review. Schizophr Res. 2018;192:50\u20136.","journal-title":"Schizophr Res"},{"issue":"2","key":"7400_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2019-100183","volume":"33","author":"J de Leon","year":"2020","unstructured":"de Leon J, et al. Clozapine is strongly associated with the risk of pneumonia and inflammation. Gen Psychiatry. 2020;33(2):e100183.","journal-title":"Gen Psychiatry"},{"issue":"5","key":"7400_CR17","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/cpt.2412","volume":"110","author":"C Lenoir","year":"2021","unstructured":"Lenoir C, et al. Impact of SARS-CoV-2 infection (COVID-19) on cytochromes P450 activity assessed by the Geneva cocktail. Clin Pharmacol Ther. 2021;110(5):1358\u201367.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"7400_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0278-5846(03)00148-9","volume":"27","author":"J de Leon","year":"2003","unstructured":"de Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(6):1059\u201363.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"7400_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/0269881116642745","volume":"30","author":"SH Gee","year":"2016","unstructured":"Gee SH, Shergill SS, Taylor DM. Factors associated with changes in hospitalisation in patients prescribed clozapine. J Psychopharmacol. 2016;30(8):819\u201325.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"7400_CR20","doi-asserted-by":"crossref","first-page":"200061","DOI":"10.1503\/jpn.2045302","volume":"45","author":"D Siskind","year":"2020","unstructured":"Siskind D, et al. Consensus statement on the use of clozapine during the COVID-19 pandemic. J Psychiatry Neurosci. 2020;45(4):200061.","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"7400_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/schbul\/sbaa070","volume":"46","author":"T Cranshaw","year":"2020","unstructured":"Cranshaw T, Harikumar T. COVID-19 infection may cause clozapine intoxication: case report and discussion. Schizophr Bull. 2020;46(4):751.","journal-title":"Schizophr Bull"},{"key":"7400_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fimmu.2019.00943","volume":"10","author":"A Pathak","year":"2019","unstructured":"Pathak A, Agrawal A. Evolution of C-reactive protein. Front Immunol. 2019;10:943.","journal-title":"Front Immunol"},{"key":"7400_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol"},{"issue":"3","key":"7400_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1385\/IR:30:3:261","volume":"30","author":"TW Du Clos","year":"2004","unstructured":"Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res. 2004;30(3):261\u201377.","journal-title":"Immunol Res"},{"key":"7400_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2019.06.010","volume":"496","author":"E Aloisio","year":"2019","unstructured":"Aloisio E, Dolci A, Panteghini M. Procalcitonin: between evidence and critical issues. Clin Chim Acta. 2019;496:7\u201312.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"7400_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/liv.14730","volume":"41","author":"AD Nardo","year":"2021","unstructured":"Nardo AD, et al. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41(1):20\u201332.","journal-title":"Liver Int"},{"issue":"1156","key":"7400_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/postgradmedj-2020-138930","volume":"98","author":"RK Saini","year":"2022","unstructured":"Saini RK, et al. COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2022;98(1156):91\u20137.","journal-title":"Postgrad Med J"},{"issue":"3","key":"7400_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai Q, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020;73(3):566\u201374.","journal-title":"J Hepatol"},{"issue":"4","key":"7400_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4103\/IJPSYM.IJPSYM_373_17","volume":"40","author":"V Chathoth","year":"2018","unstructured":"Chathoth V, Ramamurthy P, Solomon S. Clozapine-induced insulin-resistant hyperglycemia in a diabetic patient. Indian J Psychol Med. 2018;40(4):375\u20137.","journal-title":"Indian J Psychol Med"},{"issue":"1","key":"7400_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(1):64\u201377.","journal-title":"Lancet Psychiatry"},{"key":"7400_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030238","author":"M Carli","year":"2021","unstructured":"Carli M, et al. Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences. Pharmaceuticals (Basel). 2021. https:\/\/doi.org\/10.3390\/ph14030238.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"7400_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1055\/a-1625-6388","volume":"55","author":"J de Leon","year":"2022","unstructured":"de Leon J, et al. An international adult guideline for making clozapine Titration safer by using six Ancestry-Based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry. 2022;55(2):73\u201386.","journal-title":"Pharmacopsychiatry"},{"key":"7400_CR33","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad025","author":"S Pereira","year":"2023","unstructured":"Pereira S, et al. Antipsychotic-induced alterations in lipid turnover. Endocrinology. 2023. https:\/\/doi.org\/10.1210\/endocr\/bqad025.","journal-title":"Endocrinology"},{"issue":"3","key":"7400_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archinte.1969.00300130081012","volume":"123","author":"NB Ruderman","year":"1969","unstructured":"Ruderman NB, Toews CJ, Shafrir E. Role of free fatty acids in glucose homeostasis. Arch Intern Med. 1969;123(3):299\u2013313.","journal-title":"Arch Intern Med"},{"key":"7400_CR35","first-page":"92","volume":"19","author":"M Roden","year":"2004","unstructured":"Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci. 2004;19:92\u20136.","journal-title":"News Physiol Sci"},{"issue":"1","key":"7400_CR36","first-page":"89","volume":"55","author":"YL Liang","year":"2021","unstructured":"Liang YL, et al. [The clinical application of blood routine and liver and kidney function test in COVID-19 disease prediction]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55(1):89\u201395.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"2","key":"7400_CR37","volume":"69","author":"R Zakeri","year":"2021","unstructured":"Zakeri R, et al. Biological responses to COVID-19: insights from physiological and blood biomarker profiles. Curr Res Transl Med. 2021;69(2):103276.","journal-title":"Curr Res Transl Med"},{"issue":"11","key":"7400_CR38","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s00277-020-04215-y","volume":"99","author":"A Mijovic","year":"2020","unstructured":"Mijovic A, MacCabe JH. Clozapine-induced agranulocytosis. Ann Hematol. 2020;99(11):2477\u201382.","journal-title":"Ann Hematol"},{"issue":"1","key":"7400_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOH.0000000000000391","volume":"25","author":"M Wici\u0144ski","year":"2018","unstructured":"Wici\u0144ski M, W\u0119clewicz MM. Clozapine-induced agranulocytosis\/granulocytopenia: mechanisms and monitoring. Curr Opin Hematol. 2018;25(1):22\u20138.","journal-title":"Curr Opin Hematol"},{"key":"7400_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/bs.apha.2017.09.009","volume":"82","author":"JY Khokhar","year":"2018","unstructured":"Khokhar JY, et al. Unique effects of clozapine: A Pharmacological perspective. Adv Pharmacol. 2018;82:137\u201362.","journal-title":"Adv Pharmacol"},{"issue":"1","key":"7400_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1192\/bjp.2020.151","volume":"219","author":"R Govind","year":"2021","unstructured":"Govind R, et al. Clozapine treatment and risk of COVID-19 infection: retrospective cohort study. Br J Psychiatry. 2021;219(1):368\u201374.","journal-title":"Br J Psychiatry"},{"key":"7400_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cca.2020.04.024","volume":"507","author":"S Sun","year":"2020","unstructured":"Sun S, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174\u201380.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"7400_CR43","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.drudis.2020.06.022","volume":"25","author":"BO Villoutreix","year":"2020","unstructured":"Villoutreix BO, et al. Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders. Drug Discov Today. 2020;25(8):1287\u201390.","journal-title":"Drug Discov Today"},{"issue":"6","key":"7400_CR44","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/JCP.0000000000001310","volume":"40","author":"dePell\u00f3n Ruiz","year":"2020","unstructured":"Ruiz dePell\u00f3n, Santamar\u00eda \u00c1. Psychosis treatment during COVID-19 pandemic and the potential role of phenothiazines: A call for research studies. J Clin Psychopharmacol. 2020;40(6):641\u20132.","journal-title":"J Clin Psychopharmacol"},{"key":"7400_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cyto.2017.04.004","volume":"94","author":"E Obuchowicz","year":"2017","unstructured":"Obuchowicz E, et al. Different influence of antipsychotics on the balance between pro- and anti-inflammatory cytokines depends on glia activation: an in vitro study. Cytokine. 2017;94:37\u201344.","journal-title":"Cytokine"},{"key":"7400_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.schres.2022.01.035","volume":"241","author":"CR Prokopez","year":"2022","unstructured":"Prokopez CR, et al. Olanzapine, Risperidone and quetiapine: do these atypical antipsychotics have a protective effect for SARS-CoV-2? Schizophr Res. 2022;241:140\u20131.","journal-title":"Schizophr Res"},{"key":"7400_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe9403","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020. https:\/\/doi.org\/10.1126\/science.abe9403.","journal-title":"Science"},{"issue":"7816","key":"7400_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459\u201368.","journal-title":"Nature"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07400-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07400-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:03:27Z","timestamp":1763413407000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07400-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7400"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07400-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the ethics committee of Shandong Daizhuang Hospital. In this study, participants\u2019 names were discarded, and existing data were analysed. The need for\n                      informed consent\n                      was waived by the Ethics Committee of Shandong Daizhuang Hospital. All experiments were performed in accordance with the Declaration of Helsinki and relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1094"}}